SPOTLIGHT -
Slideshow
Author(s):
These concise summaries highlight the latest findings and potential remedies.
Clinical Features Associated With Response to Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression
Blue Light Blockers: A Behavior Therapy for Mania
BLP-003 for Treatment-Resistant Depression: Phase 2b Patient Enrollment Completed
Treating ‘Morally Objectionable’ Patients
Major Depressive Disorder Research Roundup: February 6, 2025
Positive Results in Phase 2b Trial of Psychedelic Agent GH001 for Treatment-Resistant Depression